Skye Bioscience, Inc. (SKYE)
1.80
+0.02
(+1.12%)
USD |
NASDAQ |
Sep 04, 16:00
1.80
0.00 (0.00%)
After-Hours: 17:28
Skye Bioscience Cash and Short Term Investments (Quarterly) : 10.06M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.06M |
| March 31, 2026 | 17.11M |
| December 31, 2025 | 25.74M |
| September 30, 2025 | 35.31M |
| June 30, 2025 | 48.59M |
| March 31, 2025 | 59.22M |
| December 31, 2024 | 68.42M |
| September 30, 2024 | 76.49M |
| June 30, 2024 | 83.20M |
| March 31, 2024 | 92.42M |
| December 31, 2023 | 10.34M |
| September 30, 2023 | 14.21M |
| June 30, 2023 | 0.558M |
| March 31, 2023 | 2.673M |
| December 31, 2022 | 1.249M |
| September 30, 2022 | 0.42M |
| June 30, 2022 | 2.934M |
| March 31, 2022 | 6.011M |
| December 31, 2021 | 8.988M |
| September 30, 2021 | 11.09M |
| June 30, 2021 | 5.191M |
| March 31, 2021 | 5.157M |
| December 31, 2020 | 2.474M |
| September 30, 2020 | 4.229M |
| June 30, 2020 | 0.1071M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5684M |
| December 31, 2019 | 1.834M |
| September 30, 2019 | 1.324M |
| June 30, 2019 | 2.812M |
| March 31, 2019 | 4.418M |
| December 31, 2018 | 1.858M |
| September 30, 2018 | 1.063M |
| June 30, 2018 | 1.879M |
| March 31, 2018 | 2.950M |
| December 31, 2017 | 0.2644M |
| September 30, 2017 | 0.0464M |
| June 30, 2017 | 0.1464M |
| March 31, 2017 | 0.4178M |
| December 31, 2016 | 0.1023M |
| September 30, 2016 | 0.3574M |
| June 30, 2016 | 0.8692M |
| March 31, 2016 | 2.099M |
| December 31, 2015 | 3.259M |
| September 30, 2015 | 4.380M |
| June 30, 2015 | 0.6013M |
| March 31, 2015 | 0.1767M |
| December 31, 2014 | 0.2073M |
| September 30, 2014 | 1.025M |
| April 30, 2014 | 0.05M |
| January 31, 2014 | 0.0465M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Viking Therapeutics, Inc. | 501.66M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |